Lindsay LeClair

Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

Ashley Fowlkes, Sarang K. Yoon, Karen Lutrick et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 183 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021

Karen Lutrick, Patrick Rivers, Young M. Yoo et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 46 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers

Gregory Joseph, John Barnes, Eduardo Azziz‐Baumgartner et al. · JAMA · 2022 · 38 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

COVID-19 Vaccination and Odds of Post–COVID-19 Condition Symptoms in Children Aged 5 to 17 Years

Anna R. Yousaf, Josephine Mak, Lisa Gwynn et al. · JAMA Network Open · 2025 · 20 citations · Full text

Medicine, Infectious Diseases, Pediatrics +17

1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022

Anna R Yousaf, Josephine Mak, Lisa Gwynn et al. · Open Forum Infectious Diseases · 2023 · 13 citations · Full text

Veterinary Medicine, Child Health, Pediatrics +17